Zaoyu Wang

发表

circPTCH1 promotes invasion and metastasis in renal cell carcinoma via regulating miR-485-5p/MMP14 axis

Yunfei Xu, W. Zhai, Yonghui Chen, 2020, Theranostics.

Genomic Profiling and Response to Immune Checkpoint Inhibition plus Tyrosine Kinase Inhibition in FH-Deficient Renal Cell Carcinoma.

Weikai He, Fangzhou Li, Ruohua Chen, 2022, European urology.

The efficacy and safety of first-line treatment in cisplatin-ineligible advanced upper tract urothelial carcinoma patients: a comparison of PD-1 inhibitor and carboplatin plus gemcitabine chemotherapy

Minfeng Chen, Jiwei Huang, Yichu Yuan, 2022, Oncoimmunology.

Expression of PBRM1 as a prognostic predictor in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitor

Jiwei Huang, Yichu Yuan, Yonghui Chen, 2019, International Journal of Clinical Oncology.

Development of a novel gene signature to predict prognosis and response to PD-1 blockade in clear cell renal cell carcinoma

W. Kong, Zaoyu Wang, Jin Zhang, 2021, Oncoimmunology.

Case Report Niemann-Pick disease: report of two cases and review of literature

Ling Zhao, Zaoyu Wang, Wei He, 2016 .

Case Report Niemann-Pick disease: report of two cases and review of literature

Ling Zhao, Zaoyu Wang, Wei He, 2016 .

Effectiveness and safety of immune checkpoint inhibitor monotherapy in advanced upper tract urothelial carcinoma: A multicenter, retrospective, real‐world study

Minfeng Chen, Jiwei Huang, Yichu Yuan, 2023, Cancer medicine.

Circulating succinate-modifying metabolites accurately classify and reflect the status of fumarate hydratase–deficient renal cell carcinoma

E. Gottlieb, Liang Zheng, Jin Zhang, 2023, The Journal of clinical investigation.

Neoadjuvant toripalimab combined with axitinib in patients with locally advanced clear cell renal cell carcinoma: a single-arm, phase II trial

Yonghui Chen, W. Kong, W. Xue, 2024, Journal for ImmunoTherapy of Cancer.